Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |